[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588663":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":34,"centralContacts":39,"locations":34,"responsibleParty":46,"collaborators":48,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":53,"sex":59,"minAge":60,"maxAge":34,"enrollmentInfo":61,"targetDuration":34,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":76,"overallStatus":85,"whyStopped":34,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":34},{"fullName":5,"class":6},"Fundacion Miguel Servet","OTHER",[8,14,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"PIVC fixed with SecurAcath 7 DAYS","PLACEBO_COMPARATOR","G1: PIVC fixed with SecurAcath, with care performed by heparinization with push-stop-push technique and positive pressure + fibrillin and semitransparent dressing change (Tergaderm 3M fully reinforced membrane dressing (TSM) every 7 days.",[13],"Other: traditional care",{"label":15,"type":16,"description":17,"interventionNames":18},"PIVC fixed with SecurAcath 14 DAYS","EXPERIMENTAL","G2: PIVC fixed with SecurAcath, with care performed by heparinization with push-stop-push technique and positive pressure + fibrillin and dressing change dressing 7 semitransparent (fully reinforced membrane dressing (TSM) Tergaderm 3M every 14 days.",[19],"Procedure: MANAGEMENT CARE",{"label":21,"type":16,"description":22,"interventionNames":23},"PIVC fixed with SecurAcath with Derma+ Flex® QS Skin Tissue Adhesive 7 days","G3: PIVC fixed with SecurAcath PLUS Derma+ Flex® QS Skin Tissue Adhesive, with care performed by heparinization with push-stop-push technique and positive pressure + sealing solution + saline and semitransparent dressing change (Tergaderm 3M fully reinforced membrane dressing (TSM) every 7 days.",[19],{"label":25,"type":16,"description":26,"interventionNames":27},"SecurAcath + Derma+ Flex® QS Skin Tissue Adhesive14 days","PIVC fixed with SecurAcath PLUS Derma+ Flex® QS Skin Tissue Adhesive, with care performed by heparinization with push-stop-push technique and positive pressure + saline + sealing solution+ saline and semitransparent dressing change (Tergaderm 3M fully reinforced membrane dressing (TSM) every 14 days.",[19],[29,35],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"PROCEDURE","MANAGEMENT CARE","Administration of the sealing element after canalization and initial treatment of the device, prior to fixation with a suture system and a 7-day vs. 14-day cadence test.",[15,21,25],null,{"type":6,"name":36,"description":37,"armGroupLabels":38,"otherNames":34},"traditional care","Traditional cure administration with sutureless device fixation every 7 days",[9],[40],{"name":41,"role":42,"phone":43,"phoneExt":44,"email":45},"Marta M Ferraz Torres, PhD","CONTACT","+34648668085","52377","marta.ferraz.torres@navarra.es",{"type":47,"investigatorFullName":34,"investigatorTitle":34,"investigatorAffiliation":34,"oldNameTitle":34,"oldOrganization":34},"SPONSOR",[49],{"name":50,"class":6},"Complejo Hospitalario de Navarra","100588663","reduction-of-complications-associated-with-picc-management-100588663",false,"NCT06944327","Reduction of Complications Associated With PICC Management","Reduction of Complications Associated With PICC Management. Randomization in Care.","PICC managemen","Inclusion Criteria:\n\n* be over 18 years of age\n* accept participation in the study\n* independent patient in the care and management of activities of daily living\n\nExclusion Criteria:\n\n* patient over 18 years of age\n* patient with functional or cognitive limitation\n* patient with mild, moderate or high level of dependence\n* patient does not accept to perform the study\n* patient with device withdrawal prior to 14 days of duration","ALL","18 Years",{"count":62,"type":63},460,"ESTIMATED","INTERVENTIONAL",[66],"NA","The present study aims to analyze different care routes of the peripheral access central venous catheter to assess which alternative allows a moderate reduction in the level of complications associated with prolonged care frequency, due to the reduction of device manipulation.\n\nA high level of patient satisfaction is detected due to the controlled follow-up of the device care, as well as a decrease in the need for transfer to a center for follow-up.\n\nObjective: Identify the type of care frequency for PIVCs most beneficial for the reduction of complications associated with extraluminal device care (thrombosis, phlebitis, accidental removal, obstruction).",[69,70,71,72,73,74,75],"Treatment Outcome","Vascular Access","Vascular Access Device","Vascular Access Complication","Care Delivery","Nurse","Nurse Based Care Management",[77,78,79,80,81,82,83,84],"vascular","vascular access","catheter","central catheter","nurse","vascular access device","management","complication","NOT_YET_RECRUITING","2025-04-23",{"date":88,"type":89},"2025-04-25","ACTUAL",{"date":91,"type":63},"2025-10-01",{"date":93,"type":63},"2027-12-31",{"name":5,"class":6}]